CTTQ PHARMA Market leader in liver medicines in China,Ranks 3rd for Chinese pharmaceutical companies with the best drug pipeline.
Imatinib Mesylate Capsule

Imatinib Mesylate Capsule



1.Indicated for the treatment of patients with Philadelphia chromosome positive(Ph+) chronic myeloid leukemia (CML) in blast crisis, accelerated phase, or in chronic phase.

2. Indicated for the treatment of pediatric patients with acute lymphoblastic leukemia(Ph+ALL) whose disease has recurred after stem cell transplant or who are resistant to interferon alpha therapy.

3. Indicated for the adults of hypereosinophilic syndrome(HES) and/or chronic eosinophilic leukemia(CEL) with FIP1L1-PDGFRα.

4. Indicated for the adults of myelodysplastic/myeloproliferative neoplasms (MDS/MPD) with platelet-derived growth factor receptors(PDGFR) gene rearrangement.

5. Indicated for the adults of aggressive systemic mastocytosis(ASM) without gene mutation of D816Vc-Kit or unknown c-Kit.

6. Indicated for the treatment of unresectable, recurred or metastatic dermatofibrosarcoma protuberans(DFSP).

contact us